drugset / Trial / NCT01495195

Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior

NCT01495195

RandomizedParallel-groupSingle-blindTreatment

Summary

No medications are currently available for treatment of psychostimulant addiction, a compulsive preoccupation with use of cocaine and related compounds. Donepezil is a medication that is currently prescribed for Alzheimer's disease, and selegiline is a medication used for treatment of Parkinson's Disease. Both of these medications can decrease the amount of cocaine injections that laboratory animals choose to inject by vein. This project will determine if combined treatment with donepezil and selegiline can also decrease cocaine-motivated behavior for human subjects in a laboratory setting.

Timeline

Start
2012-02
Primary completion
2013-05
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule 10 mg Oral
Subject Donepezil Small molecule 22.5 mg Oral
Subject Selegiline Unknown 6 mg Other